Neutrophil percentage to albumin ratio predicts all-cause and cardiovascular mortality in patients with diabetes or prediabetes from NHANES 1999-2018

中性粒细胞百分比与白蛋白比值可预测糖尿病或糖尿病前期患者的全因死亡率和心血管死亡率(数据来自1999-2018年美国国家健康与营养调查)。

阅读:1

Abstract

This cohort study investigated the association between neutrophil percentage-to-albumin ratio (NPAR) and mortality risks in U.S. adults with diabetes or prediabetes using National Health and Nutrition Examination Survey (NHANES) data (1999-2018). Among 101,316 screened participants, 47,477 eligible individuals (7,171 diabetes; 15,175 prediabetes) were analyzed after exclusions for age < 20 years, pregnancy, and missing data. NPAR was calculated as neutrophil percentage divided by albumin (g/dL). Mortality outcomes were ascertained via linkage to the National Death Index through 2019. Weighted multivariable Cox models adjusted for sociodemographic, metabolic, and clinical covariates revealed a J-shaped relationship between NPAR and mortality. Over a median follow-up of 99.5 months (IQR: 58-142), the highest NPAR quartile (Q4) demonstrated significantly elevated all-cause mortality (HR 1.585, 95% CI 1.434-1.753) and cardiovascular mortality (HR 1.642, 95% CI 1.370-1.969) compared to Q1. Restricted cubic spline analysis identified an inflection point at NPAR = 1.399. Below this threshold, NPAR associated only with cardiovascular mortality (HR 1.871, 95% CI 1.249-2.804), while values above 1.399 markedly increased risks for both all-cause (HR 3.241, 95% CI 2.343-4.483) and cardiovascular mortality (HR 2.062, 95% CI 1.213-3.503). Subgroup analyses confirmed consistency across age, gender, BMI, and comorbidity strata. These findings position NPAR as a novel integrative biomarker reflecting inflammatory-nutritional interplay, with critical prognostic value for mortality risk stratification in dysglycemic populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。